CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Sanofi and Regeneron expand immunology partnership to the tune of $8bn

PartnershipFour long-lasting antibodiesPositive
AI Analysis

Summary

Sanofi and Regeneron have expanded their immunology partnership with an $8bn agreement to co-develop and co-commercialize four long-lasting antibodies.

Importance:7/10
Sentiment:
0.70
partnershipimmunologyantibodiesco-developmentco-commercialization
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 1, 2026 10:40 AM

Read Original